CA Stock MarketDetailed Quotes

VTAL Justera Health Ltd

Watchlist
  • 0.005
  • 0.0000.00%
15min DelayMarket Closed Mar 26 10:57 ET
1.24MMarket Cap-0.25P/E (TTM)

Justera Health Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-633.77%-174.74K
90.77%-11.99K
62.83%-97.69K
23.95%-813.92K
51.79%-453.94K
169.99%32.74K
-16.32%-129.88K
-982.63%-262.84K
-113.47%-1.07M
-941.54K
Net income from continuing operations
-217.40%-3.47M
96.49%-30.62K
86.60%-122.69K
43.25%-2.98M
73.37%-99.36K
45.60%-1.09M
65.59%-872.26K
-174.22%-915.42K
48.29%-5.25M
---373.14K
Operating gains losses
--3.21K
---30K
---34K
---138.91K
--287.3K
----
----
----
----
----
Depreciation and amortization
-73.94%34.44K
-70.10%38.14K
-70.30%37.71K
-64.42%393.87K
-96.16%7.2K
-7.21%132.14K
-65.61%127.55K
-68.73%126.98K
-44.53%1.11M
--187.7K
Asset impairment expenditure
----
----
----
--4.21M
----
----
----
----
--0
----
Remuneration paid in stock
--0
--0
--0
--67.42K
---1.41K
--0
--0
--68.83K
--0
--0
Other non cashItems
99.47%981.82K
101.78%5.78K
-2,743.87%-90.76K
-459.52%-4.85M
-499.25%-5.35M
17,529.33%492.21K
-9.40%2.86K
-2.22%3.43K
-78.80%1.35M
--1.34M
Change In working capital
145.29%2.28M
-99.23%4.72K
-75.28%112.06K
43.87%2.48M
123.30%488.4K
-48.95%928.03K
-70.14%611.97K
1,087.18%453.35K
33.47%1.72M
---2.1M
-Change in receivables
-427.46%-163.69K
136.38%12.76K
99.49%-1.17K
-2,229.23%-495.75K
-191.71%-280.38K
-97.03%49.99K
85.22%-35.07K
86.68%-230.28K
-46.19%23.28K
--305.73K
-Change in inventory
-100.07%-132
-70.73%2.5K
-99.35%586
-80.04%394.14K
396.10%93.09K
-74.31%201.7K
-97.03%8.55K
-89.71%90.8K
221.36%1.97M
--18.77K
-Change in prepaid assets
122.28%30.02K
--0
98.00%-566
-95.32%4.62K
397.73%243.79K
-2,387.02%-134.75K
-267.23%-76.13K
-1,570.37%-28.3K
151.97%98.71K
--48.98K
-Change in payables and accrued expense
197.15%2.41M
-101.48%-10.55K
-81.77%113.2K
804.16%2.62M
119.11%471.91K
223.44%811.09K
-63.40%714.63K
-22.57%621.13K
-112.13%-371.9K
---2.47M
-Change in other working capital
----
----
----
---40.02K
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
-633.77%-174.74K
90.77%-11.99K
62.83%-97.69K
23.95%-813.92K
51.79%-453.94K
169.99%32.74K
-16.32%-129.88K
-982.63%-262.84K
-113.47%-1.07M
---941.54K
Investing cash flow
Cash flow from continuing investing activities
-614.62K
30K
34K
-177.47%-360.5K
-336.79%-360.5K
0
0
0
168.50%465.31K
152.24K
Net PPE purchase and sale
---3.21K
--30K
--34K
-100.71%-236.4K
-255.28%-236.4K
--0
--0
--0
85.23%-117.78K
--152.24K
Net business purchase and sale
----
----
----
-121.28%-124.1K
---124.1K
----
----
----
394.71%583.09K
--0
Cash from discontinued investing activities
Investing cash flow
---614.62K
--30K
--34K
-177.47%-360.5K
-336.79%-360.5K
--0
--0
--0
168.50%465.31K
--152.24K
Financing cash flow
Cash flow from continuing financing activities
3,603.54%788.3K
21.97%-17.56K
-15.95%-25.74K
-0.34%831.69K
2.14%898.89K
-47.06%-22.5K
-47.06%-22.5K
-48.00%-22.2K
-11.44%834.5K
880.1K
Net issuance payments of debt
47.98%-11.7K
21.97%-17.56K
-15.95%-25.74K
-57.07%-124.56K
-70.20%-57.36K
-47.06%-22.5K
-47.06%-22.5K
-48.00%-22.2K
-76.22%-79.3K
---33.7K
Net common stock issuance
----
----
----
4.65%956.25K
--956.25K
----
----
----
-7.45%913.8K
----
Cash from discontinued financing activities
Financing cash flow
3,603.54%788.3K
21.97%-17.56K
-15.95%-25.74K
-0.34%831.69K
2.14%898.89K
-47.06%-22.5K
-47.06%-22.5K
-48.00%-22.2K
-11.44%834.5K
--880.1K
Net cash flow
Beginning cash position
--5.72K
-96.55%5.26K
-78.35%94.69K
110.51%437.42K
-97.05%10.24K
--0
-85.23%152.38K
110.51%437.42K
-53.42%207.79K
--346.61K
Current changes in cash
-110.42%-1.07K
100.30%456
68.62%-89.43K
-249.25%-342.72K
-6.99%84.46K
116.49%10.24K
75.53%-152.38K
-134.61%-285.04K
196.36%229.63K
--90.81K
End cash Position
-54.58%4.65K
--5.72K
-96.55%5.26K
-78.35%94.69K
-78.35%94.69K
-97.05%10.24K
--0
-85.23%152.38K
110.51%437.42K
--437.42K
Free cash from
-633.77%-174.74K
90.77%-11.99K
62.83%-97.69K
11.59%-1.05M
12.54%-690.33K
169.99%32.74K
-7.64%-129.88K
-13.66%-262.84K
8.51%-1.19M
---789.29K
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -633.77%-174.74K90.77%-11.99K62.83%-97.69K23.95%-813.92K51.79%-453.94K169.99%32.74K-16.32%-129.88K-982.63%-262.84K-113.47%-1.07M-941.54K
Net income from continuing operations -217.40%-3.47M96.49%-30.62K86.60%-122.69K43.25%-2.98M73.37%-99.36K45.60%-1.09M65.59%-872.26K-174.22%-915.42K48.29%-5.25M---373.14K
Operating gains losses --3.21K---30K---34K---138.91K--287.3K--------------------
Depreciation and amortization -73.94%34.44K-70.10%38.14K-70.30%37.71K-64.42%393.87K-96.16%7.2K-7.21%132.14K-65.61%127.55K-68.73%126.98K-44.53%1.11M--187.7K
Asset impairment expenditure --------------4.21M------------------0----
Remuneration paid in stock --0--0--0--67.42K---1.41K--0--0--68.83K--0--0
Other non cashItems 99.47%981.82K101.78%5.78K-2,743.87%-90.76K-459.52%-4.85M-499.25%-5.35M17,529.33%492.21K-9.40%2.86K-2.22%3.43K-78.80%1.35M--1.34M
Change In working capital 145.29%2.28M-99.23%4.72K-75.28%112.06K43.87%2.48M123.30%488.4K-48.95%928.03K-70.14%611.97K1,087.18%453.35K33.47%1.72M---2.1M
-Change in receivables -427.46%-163.69K136.38%12.76K99.49%-1.17K-2,229.23%-495.75K-191.71%-280.38K-97.03%49.99K85.22%-35.07K86.68%-230.28K-46.19%23.28K--305.73K
-Change in inventory -100.07%-132-70.73%2.5K-99.35%586-80.04%394.14K396.10%93.09K-74.31%201.7K-97.03%8.55K-89.71%90.8K221.36%1.97M--18.77K
-Change in prepaid assets 122.28%30.02K--098.00%-566-95.32%4.62K397.73%243.79K-2,387.02%-134.75K-267.23%-76.13K-1,570.37%-28.3K151.97%98.71K--48.98K
-Change in payables and accrued expense 197.15%2.41M-101.48%-10.55K-81.77%113.2K804.16%2.62M119.11%471.91K223.44%811.09K-63.40%714.63K-22.57%621.13K-112.13%-371.9K---2.47M
-Change in other working capital ---------------40.02K------------------------
Cash from discontinued investing activities
Operating cash flow -633.77%-174.74K90.77%-11.99K62.83%-97.69K23.95%-813.92K51.79%-453.94K169.99%32.74K-16.32%-129.88K-982.63%-262.84K-113.47%-1.07M---941.54K
Investing cash flow
Cash flow from continuing investing activities -614.62K30K34K-177.47%-360.5K-336.79%-360.5K000168.50%465.31K152.24K
Net PPE purchase and sale ---3.21K--30K--34K-100.71%-236.4K-255.28%-236.4K--0--0--085.23%-117.78K--152.24K
Net business purchase and sale -------------121.28%-124.1K---124.1K------------394.71%583.09K--0
Cash from discontinued investing activities
Investing cash flow ---614.62K--30K--34K-177.47%-360.5K-336.79%-360.5K--0--0--0168.50%465.31K--152.24K
Financing cash flow
Cash flow from continuing financing activities 3,603.54%788.3K21.97%-17.56K-15.95%-25.74K-0.34%831.69K2.14%898.89K-47.06%-22.5K-47.06%-22.5K-48.00%-22.2K-11.44%834.5K880.1K
Net issuance payments of debt 47.98%-11.7K21.97%-17.56K-15.95%-25.74K-57.07%-124.56K-70.20%-57.36K-47.06%-22.5K-47.06%-22.5K-48.00%-22.2K-76.22%-79.3K---33.7K
Net common stock issuance ------------4.65%956.25K--956.25K-------------7.45%913.8K----
Cash from discontinued financing activities
Financing cash flow 3,603.54%788.3K21.97%-17.56K-15.95%-25.74K-0.34%831.69K2.14%898.89K-47.06%-22.5K-47.06%-22.5K-48.00%-22.2K-11.44%834.5K--880.1K
Net cash flow
Beginning cash position --5.72K-96.55%5.26K-78.35%94.69K110.51%437.42K-97.05%10.24K--0-85.23%152.38K110.51%437.42K-53.42%207.79K--346.61K
Current changes in cash -110.42%-1.07K100.30%45668.62%-89.43K-249.25%-342.72K-6.99%84.46K116.49%10.24K75.53%-152.38K-134.61%-285.04K196.36%229.63K--90.81K
End cash Position -54.58%4.65K--5.72K-96.55%5.26K-78.35%94.69K-78.35%94.69K-97.05%10.24K--0-85.23%152.38K110.51%437.42K--437.42K
Free cash from -633.77%-174.74K90.77%-11.99K62.83%-97.69K11.59%-1.05M12.54%-690.33K169.99%32.74K-7.64%-129.88K-13.66%-262.84K8.51%-1.19M---789.29K
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now

Discussing

2025 Buffett shareholders' meeting: What's the new buzz in value investing?
🎙️Discussion 1. In the face of market changes, do you prefer to stick with growth stocks or switch to value stocks? 2. Based on the current Show More